Tracey McLaughlin

Publications

• Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia. Kim SH, Liu TC, Abbasi F, Lamendola C, Morton JM, Reaven GM, McLaughlin TL. Obes Surg. 2009; 19 (11): 1550-6
• Clinical experience with a relatively low carbohydrate, calorie-restricted diet improves insulin sensitivity and associated metabolic abnormalities in overweight, insulin resistant South Asian Indian women. Backes AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven G, Palaniappan LP. Asia Pac J Clin Nutr. 2008; 17 (4): 669-71
• Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women. McLaughlin T, Deng A, Gonzales O, Aillaud M, Yee G, Lamendola C, Abbasi F, Connolly AJ, Sherman A, Cushman SW, Reaven G, Tsao PS. Diabetologia. 2008; 51 (12): 2303-8
• Persistence of improvement in insulin sensitivity following a dietary weight loss programme. McLaughlin T, Schweitzer P, Carter S, Yen CG, Lamendola C, Abbasi F, Reaven G. Diabetes Obes Metab. 2008; 10 (12): 1186-94
• Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers. Abbasi F, Farin HM, Lamendola C, McGraw L, McLaughlin T, Reaven GM. Metabolism. 2008; 57 (8): 1108-14
• Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes: comparison of moderate fat versus carbohydrate reductions. McLaughlin T, Carter S, Lamendola C, Abbasi F, Schaaf P, Basina M, Reaven G. Diabetes Care. 2007; 30 (7): 1877-9
• Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, Lamendola C, Reaven GM, Cushman SW. Diabetologia. 2007; 50 (8): 1707-15
• Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. McLaughlin T, Abbasi F, Lamendola C, Reaven G. Arch Intern Med. 2007; 167 (7): 642-8
• Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women. Palaniappan LP, Kwan AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven GM. Metabolism. 2007; 56 (7): 899-904
• Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults. Ryan MC, Abbasi F, Lamendola C, Carter S, McLaughlin TL. Diabetes Care. 2007; 30 (5): 1075-80
• The relationship between insulin resistance and dyslipidaemia in cigarette smokers. Farin HM, Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM. Diabetes Obes Metab. 2007; 9 (1): 65-9
• Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. McLaughlin T, Carter S, Lamendola C, Abbasi F, Yee G, Schaaf P, Basina M, Reaven G. Am J Clin Nutr. 2006; 84 (4): 813-21
• Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM. Hum Reprod. 2006; 21 (1): 109-20
• Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. McLaughlin T, Stühlinger M, Lamendola C, Abbasi F, Bialek J, Reaven GM, Tsao PS. J Clin Endocrinol Metab. 2006; 91 (5): 1896-900
• The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. Abbasi F, Farin HM, Lamendola C, McLaughlin T, Schwartz EA, Reaven GM, Reaven PD. J Clin Endocrinol Metab. 2006; 91 (12): 5002-7
• Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia. Lamendola C, Abbasi F, Chu JW, Hutchinson H, Cain V, Leary E, McLaughlin T, Stein E, Reaven G. Am J Cardiol. 2005; 95 (2): 189-93
• Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects. Chu JW, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Tsao PS. Diab Vasc Dis Res. 2005; 2 (1): 37-41
• Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, Krauss RM. Am J Cardiol. 2005; 96 (3): 399-404
• Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals. Kim SH, Abbasi F, Chu JW, McLaughlin TL, Lamendola C, Polonsky KS, Reaven GM. Diabetes. 2005; 54 (8): 2447-52
• Discrimination between obesity and insulin resistance in the relationship with adiponectin. Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD. Diabetes. 2004; 53 (3): 585-90
• Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus. Abbasi F, Chu JW, McLaughlin T, Lamendola C, Leary ET, Reaven GM. Metabolism. 2004; 53 (2): 159-64
• Obesity, insulin resistance, and cardiovascular disease. Reaven G, Abbasi F, McLaughlin T. Recent Prog Horm Res. 2004: 59 207-23
• Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. Abbasi F, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD. Metabolism. 2004; 53 (3): 280-3
• Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Metabolism. 2004; 53 (4): 495-9
• Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agents. Chu JW, Abbasi F, McLaughlin TL, Lamendola C, Schaaf P, Carlson TH, Leary ET, Reaven GM. Diabetes Obes Metab. 2003; 5 (5): 333-7
• Multiple lipoprotein abnormalities associated with insulin resistance in healthy volunteers are identified by the vertical auto profile-II methodology. Chu JW, Abbasi F, Kulkarni KR, Lamendola C, McLaughlin TL, Scalisi JN, Reaven GM. Clin Chem. 2003; 49 (6 Pt 1): 1014-7
• Use of metabolic markers to identify overweight individuals who are insulin resistant. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Ann Intern Med. 2003; 139 (10): 802-9
• Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance. Tuan CY, Abbasi F, Lamendola C, McLaughlin T, Reaven G. Am J Cardiol. 2003; 92 (5): 606-10
• Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl-coenzyme a reductase inhibitor treatment of combined dyslipidemia. McLaughlin T, Abbasi F, Lamendola C, Leary E, Reaven GM. Metabolism. 2002; 51 (10): 1355-9
• Differentiation between obesity and insulin resistance in the association with C-reactive protein. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, Reaven P. Circulation. 2002; 106 (23): 2908-12
• Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes. Asagami T, Abbasi F, Stuelinger M, Lamendola C, McLaughlin T, Cooke JP, Reaven GM, Tsao PS. Metabolism. 2002; 51 (7): 843-6
• Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS. JAMA. 2002; 287 (11): 1420-6
• Relationship between obesity, insulin resistance, and coronary heart disease risk. Abbasi F, Brown BW, Lamendola C, McLaughlin T, Reaven GM. J Am Coll Cardiol. 2002; 40 (5): 937-43
• Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenopausal women. Kim HS, Abbasi F, Lamendola C, McLaughlin T, Reaven GM. Am J Clin Nutr. 2001; 74 (5): 592-5
• Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone. Cataldo NA, Abbasi F, McLaughlin TL, Lamendola C, Reaven GM. Fertil Steril. 2001; 76 (5): 1057-9
• Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity. McLaughlin T, Abbasi F, Lamendola C, Kim HS, Reaven GM. Metabolism. 2001; 50 (7): 819-24
• Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stuehlinger M, Tsao PS. Am J Cardiol. 2001; 88 (10): 1201-3
• Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. McLaughlin T, Abbasi F, Kim HS, Lamendola C, Schaaf P, Reaven G. Metabolism. 2001; 50 (7): 795-800
• Carbohydrate-induced hypertriglyceridemia: an insight into the link between plasma insulin and triglyceride concentrations. McLaughlin T, Abbasi F, Lamendola C, Yeni-Komshian H, Reaven G. J Clin Endocrinol Metab. 2000; 85 (9): 3085-8
• High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk. Abbasi F, McLaughlin T, Lamendola C, Kim HS, Tanaka A, Wang T, Nakajima K, Reaven GM. Am J Cardiol. 2000; 85 (1): 45-8
• Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance. Abbasi F, McLaughlin T, Lamendola C, Reaven GM. Metabolism. 2000; 49 (2): 151-4
• Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease. McLaughlin T, Reaven G. Geriatrics. 2000; 55 (6): 28-32, 35
• Plasma insulin concentration is more tightly linked to plasma leptin concentration than is the body mass index. Abbasi F, Carantoni M, McLaughlin T, Reaven GM. Metabolism. 2000; 49 (4): 544-7
• The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers. Abbasi F, McLaughlin T, Lamendola C, Reaven GM. J Clin Endocrinol Metab. 2000; 85 (3): 1251-4
• Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women. Abbasi F, McLaughlin T, Lamendola C, Lipinska I, Tofler G, Reaven GM. Arterioscler Thromb Vasc Biol. 1999; 19 (11): 2818-21
• Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. McLaughlin T, Abbasi F, Carantoni M, Schaaf P, Reaven G. J Clin Endocrinol Metab. 1999; 84 (2): 578-81
• Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers. Abbasi F, McLaughlin T, Lamendola C, Yeni-Komshian H, Tanaka A, Wang T, Nakajima K, Reaven GM. J Clin Endocrinol Metab. 1999; 84 (11): 3903-6
• Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers. Chen NG, Abbasi F, Lamendola C, McLaughlin T, Cooke JP, Tsao PS, Reaven GM. Circulation. 1999; 100 (9): 940-3